top of page
Search

Cilex To Visit Toronto with Three Incubated Companies for Collision 2022

Gatineau, 15 June 2022 – From June 20 to 23, Cilex along with three of its incubated companies will be in Toronto for Collision 2022, joining the Quebec delegation coordinated by Investissement Québec.


The Collision Conference is one of the most important international events in the world of technological innovation. Taking place in Toronto, the conference brings together more than 30,000 participants from 120 countries yearly.


The Cilex cohort will be seated in the Quebec delegation pavilion and will be composed of Chloé Martinetti, Director of Operations and Development; Trevor Poirier, Director of Strategic Partnerships; and Charles Lapointe, innovation catalyst and coach. The three of them will be joined by startups Medzy, BioEureka and Spectronix.


“Collision is the event not to be missed in the tech world. We are pleased to be able to offer this opportunity to three of our startups, supplementing the coaching we provide them. We hope this trade mission will allow them to accelerate their development and reach their objectives even faster, notably by meeting new clients, partners, and potential investors, as well as taking a look at their competition and the current market trends,” added Chloé Martinetti, Director of Operations and Development at Cilex.


English subtitles available for the video.

This delegation is organized by Investissement Québec International in collaboration with Cilex, the Bureau du Québec à Toronto, the City of Montréal, Startup Montréal, Le Camp, Flots, 2 Degrés, Laval Économique, Desjardins Business, Granby Industrial and Les Offices jeunesse internationaux du Québec.


Cilex helps startups, companies and institutions achieve their technological innovation goals by providing a service structure in incubation, acceleration and research and development. Contact us to start your journey and learn more about our services and accomplishments.


###


Source:

Alexandre Maheux

Communications Adviser, Cilex

(819) 593-9566



Comments


bottom of page